Business Description
SOFIVA GENOMICS Co Ltd
ISIN : TW0006615008
Total Employee Number:
84Description
SOFIVA GENOMICS Co Ltd provides medical diagnostic services. The services offered by the company include Prenatal, Reproductive, Cancer, Precision Medicine, Newborn, and Rare Diseases. Its testing categories include Genetic, Biochemical, and Chromosome. The business items of Sofiva Group are pre-pregnancy, prenatal, and neonatal genetic testing and medical testing, and other service income. Geographically, it generates the vast majority of its revenue from Taiwan.
Financial Strength
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 3.51 | |||||
Equity-to-Asset | 0.87 | |||||
Debt-to-Equity | 0.06 | |||||
Debt-to-EBITDA | 1.04 | |||||
Piotroski F-Score | 5/9 | |||||
Altman Z-Score | 5.51 | |||||
Beneish M-Score | -2.52 | |||||
WACC vs ROIC | ||||||
Growth Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -8.3 | |||||
3-Year EBITDA Growth Rate | -28.3 | |||||
3-Year Book Growth Rate | -0.3 |
Momentum Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 20.2 | |||||
9-Day RSI | 31.06 | |||||
14-Day RSI | 39.3 | |||||
3-1 Month Momentum % | 2.68 | |||||
6-1 Month Momentum % | 15 | |||||
12-1 Month Momentum % | 6.48 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 3.33 | |||||
Quick Ratio | 2.84 | |||||
Cash Ratio | 1.76 | |||||
Days Inventory | 55.22 | |||||
Days Sales Outstanding | 49.55 | |||||
Days Payable | 28.85 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Dividend Yield % | 0.88 | |||||
3-Year Dividend Growth Rate | -46.9 | |||||
5-Year Yield-on-Cost % | 0.07 | |||||
3-Year Average Share Buyback Ratio | -0.4 | |||||
Shareholder Yield % | 2.93 |
Profitability Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 25.7 | |||||
Operating Margin % | -8.74 | |||||
Net Margin % | -2.43 | |||||
EBITDA Margin % | 8.85 | |||||
FCF Margin % | 1.87 | |||||
OCF Margin % | 3.98 | |||||
ROE % | -1.47 | |||||
ROA % | -1.26 | |||||
ROIC % | -6.01 | |||||
3-Year ROIIC % | -710.69 | |||||
ROC (Joel Greenblatt) % | -5.51 | |||||
ROCE % | -1.12 | |||||
Years of Profitability over Past 10-Year | 9 |
GF Value Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Shiller PE Ratio | 15.88 | |||||
Price-to-Owner-Earnings | 47.72 | |||||
PS Ratio | 1.92 | |||||
PB Ratio | 1.17 | |||||
Price-to-Tangible-Book | 1.18 | |||||
Price-to-Free-Cash-Flow | 98.41 | |||||
Price-to-Operating-Cash-Flow | 46.83 | |||||
EV-to-EBIT | -86.67 | |||||
EV-to-EBITDA | 18.93 | |||||
EV-to-Revenue | 1.68 | |||||
EV-to-FCF | 91.39 | |||||
Price-to-GF-Value | 1.1 | |||||
Price-to-Projected-FCF | 1.04 | |||||
| Price-to-Net-Current-Asset-Value | 5.25 | |||||
| Price-to-Net-Cash | 25.8 | |||||
Earnings Yield (Greenblatt) % | -1.15 | |||||
FCF Yield % | 0.98 | |||||
Forward Rate of Return (Yacktman) % | -16.18 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
SOFIVA GENOMICS Co Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil NT$) | 385.706 | ||
| EPS (TTM) (NT$) | -0.43 | ||
| Beta | -0.0074 | ||
| 3-Year Sharpe Ratio | -0.01 | ||
| 3-Year Sortino Ratio | -0.02 | ||
| Volatility % | 28.69 | ||
| 14-Day RSI | 39.3 | ||
| 14-Day ATR (NT$) | 1.016816 | ||
| 20-Day SMA (NT$) | 36.02 | ||
| 12-1 Month Momentum % | 6.48 | ||
| 52-Week Range (NT$) | 28.9 - 40 | ||
| Shares Outstanding (Mil) | 21.59 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 5 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
SOFIVA GENOMICS Co Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
SOFIVA GENOMICS Co Ltd Stock Events
| Event | Date | Price (NT$) | ||
|---|---|---|---|---|
| TWD 0.300000 Cash Dividend | 2025-06-27 | 34.15 (-5.14%) |
Show
Entries
SOFIVA GENOMICS Co Ltd Frequently Asked Questions
What is SOFIVA GENOMICS Co Ltd(ROCO:6615)'s stock price today?
The current price of ROCO:6615 is NT$34.05. The 52 week high of ROCO:6615 is NT$40.00 and 52 week low is NT$28.90.
When is next earnings date of SOFIVA GENOMICS Co Ltd(ROCO:6615)?
The next earnings date of SOFIVA GENOMICS Co Ltd(ROCO:6615) is .
Does SOFIVA GENOMICS Co Ltd(ROCO:6615) pay dividends? If so, how much?
The Dividend Yield %  of SOFIVA GENOMICS Co Ltd(ROCO:6615) is 0.88% (As of Today), Highest Dividend Payout Ratio of SOFIVA GENOMICS Co Ltd(ROCO:6615) was 1.85. The lowest was 0.23. And the median was 0.87. The  Forward Dividend Yield % of SOFIVA GENOMICS Co Ltd(ROCO:6615) is 0%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Articles on SOFIVA GENOMICS Co Ltd
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers